nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—CYP1A2—Dacarbazine—sarcoma	0.168	0.671	CbGbCtD
Anagrelide—CYP1A2—Etoposide—sarcoma	0.0824	0.328	CbGbCtD
Anagrelide—Liver function test abnormal—Doxorubicin—sarcoma	0.000992	0.00132	CcSEcCtD
Anagrelide—Skin disorder—Etoposide—sarcoma	0.000989	0.00132	CcSEcCtD
Anagrelide—Dry skin—Doxorubicin—sarcoma	0.000985	0.00132	CcSEcCtD
Anagrelide—Hyperhidrosis—Etoposide—sarcoma	0.000985	0.00131	CcSEcCtD
Anagrelide—Pancreatitis—Epirubicin—sarcoma	0.000984	0.00131	CcSEcCtD
Anagrelide—Orthostatic hypotension—Doxorubicin—sarcoma	0.000982	0.00131	CcSEcCtD
Anagrelide—Angina pectoris—Epirubicin—sarcoma	0.000978	0.00131	CcSEcCtD
Anagrelide—Urticaria—Mitoxantrone—sarcoma	0.000973	0.0013	CcSEcCtD
Anagrelide—Anorexia—Etoposide—sarcoma	0.000971	0.0013	CcSEcCtD
Anagrelide—Diarrhoea—Thiotepa—sarcoma	0.00097	0.0013	CcSEcCtD
Anagrelide—Abdominal pain—Mitoxantrone—sarcoma	0.000968	0.00129	CcSEcCtD
Anagrelide—Body temperature increased—Mitoxantrone—sarcoma	0.000968	0.00129	CcSEcCtD
Anagrelide—Bronchitis—Epirubicin—sarcoma	0.000966	0.00129	CcSEcCtD
Anagrelide—Diarrhoea—Dactinomycin—sarcoma	0.000963	0.00129	CcSEcCtD
Anagrelide—Pancytopenia—Epirubicin—sarcoma	0.000954	0.00127	CcSEcCtD
Anagrelide—Hypotension—Etoposide—sarcoma	0.000952	0.00127	CcSEcCtD
Anagrelide—Gastritis—Doxorubicin—sarcoma	0.000951	0.00127	CcSEcCtD
Anagrelide—Dysuria—Epirubicin—sarcoma	0.000939	0.00125	CcSEcCtD
Anagrelide—Dizziness—Thiotepa—sarcoma	0.000938	0.00125	CcSEcCtD
Anagrelide—Influenza—Doxorubicin—sarcoma	0.000929	0.00124	CcSEcCtD
Anagrelide—Asthma—Doxorubicin—sarcoma	0.000929	0.00124	CcSEcCtD
Anagrelide—Dysphagia—Doxorubicin—sarcoma	0.000929	0.00124	CcSEcCtD
Anagrelide—Pollakiuria—Epirubicin—sarcoma	0.000928	0.00124	CcSEcCtD
Anagrelide—Photosensitivity reaction—Epirubicin—sarcoma	0.000917	0.00122	CcSEcCtD
Anagrelide—Paraesthesia—Etoposide—sarcoma	0.000915	0.00122	CcSEcCtD
Anagrelide—Weight increased—Epirubicin—sarcoma	0.000914	0.00122	CcSEcCtD
Anagrelide—Pancreatitis—Doxorubicin—sarcoma	0.000911	0.00122	CcSEcCtD
Anagrelide—Weight decreased—Epirubicin—sarcoma	0.000908	0.00121	CcSEcCtD
Anagrelide—Dyspnoea—Etoposide—sarcoma	0.000908	0.00121	CcSEcCtD
Anagrelide—Somnolence—Etoposide—sarcoma	0.000906	0.00121	CcSEcCtD
Anagrelide—Angina pectoris—Doxorubicin—sarcoma	0.000905	0.00121	CcSEcCtD
Anagrelide—Asthenia—Vincristine—sarcoma	0.000902	0.0012	CcSEcCtD
Anagrelide—Vomiting—Thiotepa—sarcoma	0.000902	0.0012	CcSEcCtD
Anagrelide—Pneumonia—Epirubicin—sarcoma	0.000901	0.0012	CcSEcCtD
Anagrelide—Vomiting—Dactinomycin—sarcoma	0.000895	0.00119	CcSEcCtD
Anagrelide—Rash—Thiotepa—sarcoma	0.000894	0.00119	CcSEcCtD
Anagrelide—Bronchitis—Doxorubicin—sarcoma	0.000894	0.00119	CcSEcCtD
Anagrelide—Dermatitis—Thiotepa—sarcoma	0.000893	0.00119	CcSEcCtD
Anagrelide—Headache—Thiotepa—sarcoma	0.000888	0.00119	CcSEcCtD
Anagrelide—Rash—Dactinomycin—sarcoma	0.000887	0.00118	CcSEcCtD
Anagrelide—Decreased appetite—Etoposide—sarcoma	0.000886	0.00118	CcSEcCtD
Anagrelide—Pancytopenia—Doxorubicin—sarcoma	0.000882	0.00118	CcSEcCtD
Anagrelide—Renal failure—Epirubicin—sarcoma	0.00088	0.00117	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Etoposide—sarcoma	0.000879	0.00117	CcSEcCtD
Anagrelide—Asthenia—Mitoxantrone—sarcoma	0.000879	0.00117	CcSEcCtD
Anagrelide—Fatigue—Etoposide—sarcoma	0.000878	0.00117	CcSEcCtD
Anagrelide—Constipation—Etoposide—sarcoma	0.000871	0.00116	CcSEcCtD
Anagrelide—Pain—Etoposide—sarcoma	0.000871	0.00116	CcSEcCtD
Anagrelide—Urinary tract infection—Epirubicin—sarcoma	0.00087	0.00116	CcSEcCtD
Anagrelide—Conjunctivitis—Epirubicin—sarcoma	0.00087	0.00116	CcSEcCtD
Anagrelide—Dysuria—Doxorubicin—sarcoma	0.000869	0.00116	CcSEcCtD
Anagrelide—Diarrhoea—Vincristine—sarcoma	0.00086	0.00115	CcSEcCtD
Anagrelide—Sweating—Epirubicin—sarcoma	0.000858	0.00115	CcSEcCtD
Anagrelide—Pollakiuria—Doxorubicin—sarcoma	0.000858	0.00115	CcSEcCtD
Anagrelide—Haematuria—Epirubicin—sarcoma	0.000854	0.00114	CcSEcCtD
Anagrelide—Photosensitivity reaction—Doxorubicin—sarcoma	0.000848	0.00113	CcSEcCtD
Anagrelide—Hepatobiliary disease—Epirubicin—sarcoma	0.000847	0.00113	CcSEcCtD
Anagrelide—Weight increased—Doxorubicin—sarcoma	0.000846	0.00113	CcSEcCtD
Anagrelide—Epistaxis—Epirubicin—sarcoma	0.000844	0.00113	CcSEcCtD
Anagrelide—Nausea—Thiotepa—sarcoma	0.000842	0.00112	CcSEcCtD
Anagrelide—Weight decreased—Doxorubicin—sarcoma	0.000841	0.00112	CcSEcCtD
Anagrelide—Sinusitis—Epirubicin—sarcoma	0.00084	0.00112	CcSEcCtD
Anagrelide—Feeling abnormal—Etoposide—sarcoma	0.000839	0.00112	CcSEcCtD
Anagrelide—Diarrhoea—Mitoxantrone—sarcoma	0.000838	0.00112	CcSEcCtD
Anagrelide—Nausea—Dactinomycin—sarcoma	0.000836	0.00112	CcSEcCtD
Anagrelide—Pneumonia—Doxorubicin—sarcoma	0.000833	0.00111	CcSEcCtD
Anagrelide—Gastrointestinal pain—Etoposide—sarcoma	0.000833	0.00111	CcSEcCtD
Anagrelide—Dizziness—Vincristine—sarcoma	0.000832	0.00111	CcSEcCtD
Anagrelide—Renal failure—Doxorubicin—sarcoma	0.000814	0.00109	CcSEcCtD
Anagrelide—Urticaria—Etoposide—sarcoma	0.000809	0.00108	CcSEcCtD
Anagrelide—Haemoglobin—Epirubicin—sarcoma	0.000808	0.00108	CcSEcCtD
Anagrelide—Rhinitis—Epirubicin—sarcoma	0.000806	0.00108	CcSEcCtD
Anagrelide—Body temperature increased—Etoposide—sarcoma	0.000805	0.00108	CcSEcCtD
Anagrelide—Abdominal pain—Etoposide—sarcoma	0.000805	0.00108	CcSEcCtD
Anagrelide—Conjunctivitis—Doxorubicin—sarcoma	0.000805	0.00108	CcSEcCtD
Anagrelide—Urinary tract infection—Doxorubicin—sarcoma	0.000805	0.00108	CcSEcCtD
Anagrelide—Haemorrhage—Epirubicin—sarcoma	0.000804	0.00107	CcSEcCtD
Anagrelide—Hepatitis—Epirubicin—sarcoma	0.000804	0.00107	CcSEcCtD
Anagrelide—Hypoaesthesia—Epirubicin—sarcoma	0.0008	0.00107	CcSEcCtD
Anagrelide—Vomiting—Vincristine—sarcoma	0.0008	0.00107	CcSEcCtD
Anagrelide—Pharyngitis—Epirubicin—sarcoma	0.000798	0.00106	CcSEcCtD
Anagrelide—Sweating—Doxorubicin—sarcoma	0.000794	0.00106	CcSEcCtD
Anagrelide—Urinary tract disorder—Epirubicin—sarcoma	0.000794	0.00106	CcSEcCtD
Anagrelide—Rash—Vincristine—sarcoma	0.000793	0.00106	CcSEcCtD
Anagrelide—Dermatitis—Vincristine—sarcoma	0.000792	0.00106	CcSEcCtD
Anagrelide—Oedema peripheral—Epirubicin—sarcoma	0.000792	0.00106	CcSEcCtD
Anagrelide—Haematuria—Doxorubicin—sarcoma	0.00079	0.00105	CcSEcCtD
Anagrelide—Connective tissue disorder—Epirubicin—sarcoma	0.00079	0.00105	CcSEcCtD
Anagrelide—Urethral disorder—Epirubicin—sarcoma	0.000788	0.00105	CcSEcCtD
Anagrelide—Headache—Vincristine—sarcoma	0.000788	0.00105	CcSEcCtD
Anagrelide—Hepatobiliary disease—Doxorubicin—sarcoma	0.000783	0.00105	CcSEcCtD
Anagrelide—Epistaxis—Doxorubicin—sarcoma	0.000781	0.00104	CcSEcCtD
Anagrelide—Vomiting—Mitoxantrone—sarcoma	0.000779	0.00104	CcSEcCtD
Anagrelide—Sinusitis—Doxorubicin—sarcoma	0.000777	0.00104	CcSEcCtD
Anagrelide—Visual impairment—Epirubicin—sarcoma	0.000775	0.00103	CcSEcCtD
Anagrelide—Rash—Mitoxantrone—sarcoma	0.000772	0.00103	CcSEcCtD
Anagrelide—Dermatitis—Mitoxantrone—sarcoma	0.000771	0.00103	CcSEcCtD
Anagrelide—Headache—Mitoxantrone—sarcoma	0.000767	0.00102	CcSEcCtD
Anagrelide—Eye disorder—Epirubicin—sarcoma	0.000751	0.001	CcSEcCtD
Anagrelide—Tinnitus—Epirubicin—sarcoma	0.000749	0.001	CcSEcCtD
Anagrelide—Haemoglobin—Doxorubicin—sarcoma	0.000747	0.000998	CcSEcCtD
Anagrelide—Nausea—Vincristine—sarcoma	0.000747	0.000997	CcSEcCtD
Anagrelide—Cardiac disorder—Epirubicin—sarcoma	0.000746	0.000996	CcSEcCtD
Anagrelide—Rhinitis—Doxorubicin—sarcoma	0.000746	0.000995	CcSEcCtD
Anagrelide—Hepatitis—Doxorubicin—sarcoma	0.000744	0.000993	CcSEcCtD
Anagrelide—Haemorrhage—Doxorubicin—sarcoma	0.000744	0.000993	CcSEcCtD
Anagrelide—Hypoaesthesia—Doxorubicin—sarcoma	0.00074	0.000988	CcSEcCtD
Anagrelide—Pharyngitis—Doxorubicin—sarcoma	0.000738	0.000985	CcSEcCtD
Anagrelide—Urinary tract disorder—Doxorubicin—sarcoma	0.000734	0.00098	CcSEcCtD
Anagrelide—Oedema peripheral—Doxorubicin—sarcoma	0.000733	0.000978	CcSEcCtD
Anagrelide—Asthenia—Etoposide—sarcoma	0.000731	0.000976	CcSEcCtD
Anagrelide—Connective tissue disorder—Doxorubicin—sarcoma	0.000731	0.000976	CcSEcCtD
Anagrelide—Urethral disorder—Doxorubicin—sarcoma	0.000729	0.000973	CcSEcCtD
Anagrelide—Nausea—Mitoxantrone—sarcoma	0.000727	0.000971	CcSEcCtD
Anagrelide—Mediastinal disorder—Epirubicin—sarcoma	0.000724	0.000967	CcSEcCtD
Anagrelide—Chills—Epirubicin—sarcoma	0.000721	0.000963	CcSEcCtD
Anagrelide—Pruritus—Etoposide—sarcoma	0.000721	0.000962	CcSEcCtD
Anagrelide—Arrhythmia—Epirubicin—sarcoma	0.000718	0.000959	CcSEcCtD
Anagrelide—Visual impairment—Doxorubicin—sarcoma	0.000717	0.000957	CcSEcCtD
Anagrelide—Alopecia—Epirubicin—sarcoma	0.00071	0.000948	CcSEcCtD
Anagrelide—Malnutrition—Epirubicin—sarcoma	0.0007	0.000934	CcSEcCtD
Anagrelide—Diarrhoea—Etoposide—sarcoma	0.000697	0.00093	CcSEcCtD
Anagrelide—Eye disorder—Doxorubicin—sarcoma	0.000695	0.000928	CcSEcCtD
Anagrelide—Tinnitus—Doxorubicin—sarcoma	0.000693	0.000926	CcSEcCtD
Anagrelide—Cardiac disorder—Doxorubicin—sarcoma	0.00069	0.000921	CcSEcCtD
Anagrelide—Flatulence—Epirubicin—sarcoma	0.000689	0.00092	CcSEcCtD
Anagrelide—Tension—Epirubicin—sarcoma	0.000687	0.000917	CcSEcCtD
Anagrelide—Nervousness—Epirubicin—sarcoma	0.00068	0.000907	CcSEcCtD
Anagrelide—Back pain—Epirubicin—sarcoma	0.000677	0.000904	CcSEcCtD
Anagrelide—Dizziness—Etoposide—sarcoma	0.000674	0.000899	CcSEcCtD
Anagrelide—Muscle spasms—Epirubicin—sarcoma	0.000673	0.000898	CcSEcCtD
Anagrelide—Mediastinal disorder—Doxorubicin—sarcoma	0.00067	0.000895	CcSEcCtD
Anagrelide—Chills—Doxorubicin—sarcoma	0.000667	0.000891	CcSEcCtD
Anagrelide—Arrhythmia—Doxorubicin—sarcoma	0.000664	0.000887	CcSEcCtD
Anagrelide—Vision blurred—Epirubicin—sarcoma	0.000659	0.00088	CcSEcCtD
Anagrelide—Alopecia—Doxorubicin—sarcoma	0.000657	0.000877	CcSEcCtD
Anagrelide—Ill-defined disorder—Epirubicin—sarcoma	0.000649	0.000867	CcSEcCtD
Anagrelide—Vomiting—Etoposide—sarcoma	0.000648	0.000865	CcSEcCtD
Anagrelide—Malnutrition—Doxorubicin—sarcoma	0.000647	0.000864	CcSEcCtD
Anagrelide—Anaemia—Epirubicin—sarcoma	0.000647	0.000863	CcSEcCtD
Anagrelide—Rash—Etoposide—sarcoma	0.000642	0.000857	CcSEcCtD
Anagrelide—Dermatitis—Etoposide—sarcoma	0.000642	0.000857	CcSEcCtD
Anagrelide—Headache—Etoposide—sarcoma	0.000638	0.000852	CcSEcCtD
Anagrelide—Flatulence—Doxorubicin—sarcoma	0.000638	0.000852	CcSEcCtD
Anagrelide—Tension—Doxorubicin—sarcoma	0.000635	0.000848	CcSEcCtD
Anagrelide—Malaise—Epirubicin—sarcoma	0.000631	0.000842	CcSEcCtD
Anagrelide—Nervousness—Doxorubicin—sarcoma	0.000629	0.000839	CcSEcCtD
Anagrelide—Syncope—Epirubicin—sarcoma	0.000627	0.000838	CcSEcCtD
Anagrelide—Back pain—Doxorubicin—sarcoma	0.000626	0.000836	CcSEcCtD
Anagrelide—Muscle spasms—Doxorubicin—sarcoma	0.000622	0.000831	CcSEcCtD
Anagrelide—Palpitations—Epirubicin—sarcoma	0.000618	0.000825	CcSEcCtD
Anagrelide—Loss of consciousness—Epirubicin—sarcoma	0.000615	0.000821	CcSEcCtD
Anagrelide—Cough—Epirubicin—sarcoma	0.000611	0.000815	CcSEcCtD
Anagrelide—Vision blurred—Doxorubicin—sarcoma	0.00061	0.000815	CcSEcCtD
Anagrelide—Convulsion—Epirubicin—sarcoma	0.000606	0.000809	CcSEcCtD
Anagrelide—Nausea—Etoposide—sarcoma	0.000605	0.000808	CcSEcCtD
Anagrelide—Hypertension—Epirubicin—sarcoma	0.000604	0.000806	CcSEcCtD
Anagrelide—Ill-defined disorder—Doxorubicin—sarcoma	0.000601	0.000802	CcSEcCtD
Anagrelide—Anaemia—Doxorubicin—sarcoma	0.000598	0.000799	CcSEcCtD
Anagrelide—Arthralgia—Epirubicin—sarcoma	0.000596	0.000795	CcSEcCtD
Anagrelide—Chest pain—Epirubicin—sarcoma	0.000596	0.000795	CcSEcCtD
Anagrelide—Myalgia—Epirubicin—sarcoma	0.000596	0.000795	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000592	0.00079	CcSEcCtD
Anagrelide—Discomfort—Epirubicin—sarcoma	0.000589	0.000786	CcSEcCtD
Anagrelide—Malaise—Doxorubicin—sarcoma	0.000584	0.000779	CcSEcCtD
Anagrelide—Dry mouth—Epirubicin—sarcoma	0.000583	0.000778	CcSEcCtD
Anagrelide—Syncope—Doxorubicin—sarcoma	0.000581	0.000775	CcSEcCtD
Anagrelide—Confusional state—Epirubicin—sarcoma	0.000576	0.000769	CcSEcCtD
Anagrelide—Palpitations—Doxorubicin—sarcoma	0.000572	0.000764	CcSEcCtD
Anagrelide—Oedema—Epirubicin—sarcoma	0.000571	0.000762	CcSEcCtD
Anagrelide—Loss of consciousness—Doxorubicin—sarcoma	0.000569	0.00076	CcSEcCtD
Anagrelide—Infection—Epirubicin—sarcoma	0.000567	0.000757	CcSEcCtD
Anagrelide—Cough—Doxorubicin—sarcoma	0.000565	0.000754	CcSEcCtD
Anagrelide—Shock—Epirubicin—sarcoma	0.000562	0.00075	CcSEcCtD
Anagrelide—Convulsion—Doxorubicin—sarcoma	0.000561	0.000749	CcSEcCtD
Anagrelide—Nervous system disorder—Epirubicin—sarcoma	0.00056	0.000748	CcSEcCtD
Anagrelide—Thrombocytopenia—Epirubicin—sarcoma	0.000559	0.000746	CcSEcCtD
Anagrelide—Hypertension—Doxorubicin—sarcoma	0.000559	0.000746	CcSEcCtD
Anagrelide—Tachycardia—Epirubicin—sarcoma	0.000557	0.000744	CcSEcCtD
Anagrelide—Skin disorder—Epirubicin—sarcoma	0.000555	0.00074	CcSEcCtD
Anagrelide—Hyperhidrosis—Epirubicin—sarcoma	0.000552	0.000737	CcSEcCtD
Anagrelide—Chest pain—Doxorubicin—sarcoma	0.000551	0.000736	CcSEcCtD
Anagrelide—Myalgia—Doxorubicin—sarcoma	0.000551	0.000736	CcSEcCtD
Anagrelide—Arthralgia—Doxorubicin—sarcoma	0.000551	0.000736	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000547	0.000731	CcSEcCtD
Anagrelide—Discomfort—Doxorubicin—sarcoma	0.000545	0.000727	CcSEcCtD
Anagrelide—Anorexia—Epirubicin—sarcoma	0.000544	0.000727	CcSEcCtD
Anagrelide—Dry mouth—Doxorubicin—sarcoma	0.000539	0.00072	CcSEcCtD
Anagrelide—Hypotension—Epirubicin—sarcoma	0.000534	0.000712	CcSEcCtD
Anagrelide—Confusional state—Doxorubicin—sarcoma	0.000533	0.000711	CcSEcCtD
Anagrelide—Oedema—Doxorubicin—sarcoma	0.000528	0.000705	CcSEcCtD
Anagrelide—Infection—Doxorubicin—sarcoma	0.000525	0.000701	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00052	0.000695	CcSEcCtD
Anagrelide—Shock—Doxorubicin—sarcoma	0.00052	0.000694	CcSEcCtD
Anagrelide—Nervous system disorder—Doxorubicin—sarcoma	0.000518	0.000692	CcSEcCtD
Anagrelide—Thrombocytopenia—Doxorubicin—sarcoma	0.000517	0.000691	CcSEcCtD
Anagrelide—Insomnia—Epirubicin—sarcoma	0.000516	0.000689	CcSEcCtD
Anagrelide—Tachycardia—Doxorubicin—sarcoma	0.000516	0.000688	CcSEcCtD
Anagrelide—Skin disorder—Doxorubicin—sarcoma	0.000513	0.000685	CcSEcCtD
Anagrelide—Paraesthesia—Epirubicin—sarcoma	0.000513	0.000685	CcSEcCtD
Anagrelide—Hyperhidrosis—Doxorubicin—sarcoma	0.000511	0.000682	CcSEcCtD
Anagrelide—Dyspnoea—Epirubicin—sarcoma	0.000509	0.00068	CcSEcCtD
Anagrelide—Somnolence—Epirubicin—sarcoma	0.000508	0.000678	CcSEcCtD
Anagrelide—Anorexia—Doxorubicin—sarcoma	0.000504	0.000672	CcSEcCtD
Anagrelide—Dyspepsia—Epirubicin—sarcoma	0.000503	0.000671	CcSEcCtD
Anagrelide—Decreased appetite—Epirubicin—sarcoma	0.000496	0.000663	CcSEcCtD
Anagrelide—Hypotension—Doxorubicin—sarcoma	0.000494	0.000659	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000493	0.000658	CcSEcCtD
Anagrelide—Fatigue—Epirubicin—sarcoma	0.000492	0.000657	CcSEcCtD
Anagrelide—Constipation—Epirubicin—sarcoma	0.000488	0.000652	CcSEcCtD
Anagrelide—Pain—Epirubicin—sarcoma	0.000488	0.000652	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000481	0.000643	CcSEcCtD
Anagrelide—Insomnia—Doxorubicin—sarcoma	0.000478	0.000638	CcSEcCtD
Anagrelide—Paraesthesia—Doxorubicin—sarcoma	0.000474	0.000633	CcSEcCtD
Anagrelide—Dyspnoea—Doxorubicin—sarcoma	0.000471	0.000629	CcSEcCtD
Anagrelide—Feeling abnormal—Epirubicin—sarcoma	0.000471	0.000628	CcSEcCtD
Anagrelide—Somnolence—Doxorubicin—sarcoma	0.00047	0.000627	CcSEcCtD
Anagrelide—Gastrointestinal pain—Epirubicin—sarcoma	0.000467	0.000623	CcSEcCtD
Anagrelide—Dyspepsia—Doxorubicin—sarcoma	0.000465	0.000621	CcSEcCtD
Anagrelide—Decreased appetite—Doxorubicin—sarcoma	0.000459	0.000613	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000456	0.000609	CcSEcCtD
Anagrelide—Fatigue—Doxorubicin—sarcoma	0.000456	0.000608	CcSEcCtD
Anagrelide—Urticaria—Epirubicin—sarcoma	0.000454	0.000606	CcSEcCtD
Anagrelide—Pain—Doxorubicin—sarcoma	0.000452	0.000603	CcSEcCtD
Anagrelide—Constipation—Doxorubicin—sarcoma	0.000452	0.000603	CcSEcCtD
Anagrelide—Abdominal pain—Epirubicin—sarcoma	0.000451	0.000603	CcSEcCtD
Anagrelide—Body temperature increased—Epirubicin—sarcoma	0.000451	0.000603	CcSEcCtD
Anagrelide—Feeling abnormal—Doxorubicin—sarcoma	0.000435	0.000581	CcSEcCtD
Anagrelide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000432	0.000577	CcSEcCtD
Anagrelide—Urticaria—Doxorubicin—sarcoma	0.00042	0.00056	CcSEcCtD
Anagrelide—Body temperature increased—Doxorubicin—sarcoma	0.000418	0.000558	CcSEcCtD
Anagrelide—Abdominal pain—Doxorubicin—sarcoma	0.000418	0.000558	CcSEcCtD
Anagrelide—Asthenia—Epirubicin—sarcoma	0.00041	0.000547	CcSEcCtD
Anagrelide—Pruritus—Epirubicin—sarcoma	0.000404	0.000539	CcSEcCtD
Anagrelide—Diarrhoea—Epirubicin—sarcoma	0.000391	0.000522	CcSEcCtD
Anagrelide—Asthenia—Doxorubicin—sarcoma	0.000379	0.000506	CcSEcCtD
Anagrelide—Dizziness—Epirubicin—sarcoma	0.000378	0.000504	CcSEcCtD
Anagrelide—Pruritus—Doxorubicin—sarcoma	0.000374	0.000499	CcSEcCtD
Anagrelide—Vomiting—Epirubicin—sarcoma	0.000363	0.000485	CcSEcCtD
Anagrelide—Diarrhoea—Doxorubicin—sarcoma	0.000362	0.000483	CcSEcCtD
Anagrelide—Rash—Epirubicin—sarcoma	0.00036	0.000481	CcSEcCtD
Anagrelide—Dermatitis—Epirubicin—sarcoma	0.00036	0.00048	CcSEcCtD
Anagrelide—Headache—Epirubicin—sarcoma	0.000358	0.000478	CcSEcCtD
Anagrelide—Dizziness—Doxorubicin—sarcoma	0.000349	0.000466	CcSEcCtD
Anagrelide—Nausea—Epirubicin—sarcoma	0.000339	0.000453	CcSEcCtD
Anagrelide—Vomiting—Doxorubicin—sarcoma	0.000336	0.000448	CcSEcCtD
Anagrelide—Rash—Doxorubicin—sarcoma	0.000333	0.000445	CcSEcCtD
Anagrelide—Dermatitis—Doxorubicin—sarcoma	0.000333	0.000444	CcSEcCtD
Anagrelide—Headache—Doxorubicin—sarcoma	0.000331	0.000442	CcSEcCtD
Anagrelide—Nausea—Doxorubicin—sarcoma	0.000314	0.000419	CcSEcCtD
